Pune's health department has vaccinated over 4,524 adults with the BCG vaccine in a study to assess its efficacy against tuberculosis over three...
Vous n'êtes pas connecté
India's first phase-three trial for an indigenous tetravalent dengue vaccine, DengiALL, was initiated by Panacea Biotec. Conducted across 19 sites, the trial involves over 10,335 healthy adults. The vaccine aims to address all four dengue serotypes. The Union Health Minister J P Nadda highlighted its significance in combating dengue and enhancing India's vaccine development capabilities.
Pune's health department has vaccinated over 4,524 adults with the BCG vaccine in a study to assess its efficacy against tuberculosis over three...
Shri Jagat Prakash Nadda inaugurates the National Medical Register (NMR) Portal, a key step in enhancing India's digital healthcare ecosystem with...
The strategic landscape of naval warfare has undergone a remarkable transformation over the past few decades, with nations increasingly focusing on...
HAL has signed a contract with Safhal Helicopter Engines Pvt Ltd to co-develop the ‘Aravalli’ engine for India’s forthcoming Multi-Role...
The Cuban National Health System applies from today the Pneumosil10 valent vaccine to all infants born this year, which prevents 10 of the main...
The Cuban National Health System applies from today the Pneumosil10 valent vaccine to all infants born this year, which prevents 10 of the main...
India recently launched its second nuclear-powered submarine, the INS Arighat, in Visakhapatnam. Defence Minister Rajnath Singh and other...
The European Commission approves GSK's RSV vaccine, Arexvy, for use in adults aged 50-59 years with increased risk of the disease.
The study investigates COVID-19 vaccine-related myocarditis in adolescents, revealing clinical characteristics and risks of myocardial injury in young...
On Thursday (September 5), Defence Minister Rajnath Singh chaired the maiden Joint Commanders’ Conference in Lucknow. He stressed the need for...